D. E. Shaw & Co., Inc. - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 106 filers reported holding RAPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.4%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$320,443
-81.8%
17,136
-82.2%
0.00%
-100.0%
Q1 2023$1,762,738
-29.7%
96,062
-24.2%
0.00%
-33.3%
Q4 2022$2,508,759
+4.8%
126,705
+27.4%
0.00%0.0%
Q3 2022$2,393,000
-5.1%
99,480
+44.9%
0.00%
+50.0%
Q4 2021$2,521,000
-36.5%
68,648
-46.3%
0.00%
-50.0%
Q3 2021$3,967,000
+160.6%
127,768
+166.8%
0.00%
+300.0%
Q2 2021$1,522,00047,8830.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$29,189,00046.08%
KPCB XV Associates, LLC 1,297,063$23,671,00043.66%
Column Group LLC 2,680,458$48,918,00010.41%
Ponoi II Management, LLC 145,401$2,654,0007.21%
Euclidean Capital LLC 432,900$7,900,0006.72%
AJU IB Investment Co., Ltd. 99,503$1,816,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,023,321$18,676,0003.17%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 443,619$8,096,0001.62%
Ghost Tree Capital, LLC 165,000$3,011,0001.57%
Perceptive Advisors 1,913,791$34,927,0001.09%
View complete list of RAPT THERAPEUTICS INC shareholders